These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7722295)

  • 21. A major role for matrix metalloproteinases in T cell injury in the gut.
    Pender SL; Tickle SP; Docherty AJ; Howie D; Wathen NC; MacDonald TT
    J Immunol; 1997 Feb; 158(4):1582-90. PubMed ID: 9029093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B.
    Giannelli G; Brassard J; Foti C; Stetler-Stevenson WG; Falk-Marzillier J; Zambonin-Zallone A; Schiraldi O; Quaranta V
    Lab Invest; 1996 Jun; 74(6):1091-104. PubMed ID: 8667613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
    Ye HQ; Azar DT
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):913-21. PubMed ID: 9579471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of matrix metalloproteinase-2 and -9 during early human wound healing.
    Salo T; Mäkelä M; Kylmäniemi M; Autio-Harmainen H; Larjava H
    Lab Invest; 1994 Feb; 70(2):176-82. PubMed ID: 8139259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Meade-Tollin LC; Way D; Witte MH
    Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
    Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
    Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
    Li L; Akers K; Eisen AZ; Seltzer JL
    Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
    Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
    Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase inhibitors: a structure-activity study.
    Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
    J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung alveolar epithelial cells synthesize interstitial collagenase and gelatinases A and B in vitro.
    Pardo A; Ridge K; Uhal B; Sznajder JI; Selman M
    Int J Biochem Cell Biol; 1997 Jun; 29(6):901-10. PubMed ID: 9304805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective modulation of collagenase 1 gene expression by the chemotherapeutic agent doxorubicin.
    Benbow U; Maitra R; Hamilton JW; Brinckerhoff CE
    Clin Cancer Res; 1999 Jan; 5(1):203-8. PubMed ID: 9918220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
    Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
    J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro.
    Lelongt B; Trugnan G; Murphy G; Ronco PM
    J Cell Biol; 1997 Mar; 136(6):1363-73. PubMed ID: 9087449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
    Lenz O; Striker LJ; Jacot TA; Elliot SJ; Killen PD; Striker GE
    J Am Soc Nephrol; 1998 Nov; 9(11):2040-7. PubMed ID: 9808089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alveolar epithelial cells in vitro produce gelatinases and tissue inhibitor of matrix metalloproteinase-2.
    d'Ortho MP; Clerici C; Yao PM; Delacourt C; Delclaux C; Franco-Montoya ML; Harf A; Lafuma C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):L663-75. PubMed ID: 9316503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.
    Rajagopalan S; Meng XP; Ramasamy S; Harrison DG; Galis ZS
    J Clin Invest; 1996 Dec; 98(11):2572-9. PubMed ID: 8958220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
    Paemen L; Martens E; Masure S; Opdenakker G
    Eur J Biochem; 1995 Dec; 234(3):759-65. PubMed ID: 8575432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.